Medpace Holdings Inc (MEDP)
406.45
+30.41
(+8.09%)
USD |
NASDAQ |
Apr 23, 16:00
406.53
+0.08
(+0.02%)
After-Hours: 17:12
Medpace Holdings 1 Year Total Returns (Daily): 98.95% for April 22, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 22, 2024 | 98.95% |
April 19, 2024 | 92.47% |
April 18, 2024 | 95.28% |
April 17, 2024 | 95.60% |
April 16, 2024 | 100.4% |
April 15, 2024 | 101.5% |
April 12, 2024 | 108.4% |
April 11, 2024 | 110.0% |
April 10, 2024 | 108.5% |
April 09, 2024 | 112.0% |
April 08, 2024 | 114.1% |
April 05, 2024 | 111.7% |
April 04, 2024 | 103.0% |
April 03, 2024 | 108.3% |
April 02, 2024 | 108.7% |
April 01, 2024 | 111.6% |
March 28, 2024 | 122.6% |
March 27, 2024 | 120.1% |
March 26, 2024 | 121.4% |
March 25, 2024 | 121.1% |
March 22, 2024 | 128.7% |
March 21, 2024 | 124.0% |
March 20, 2024 | 122.0% |
March 19, 2024 | 122.0% |
March 18, 2024 | 122.6% |
Date | Value |
---|---|
March 15, 2024 | 123.0% |
March 14, 2024 | 123.0% |
March 13, 2024 | 134.0% |
March 12, 2024 | 132.3% |
March 11, 2024 | 129.9% |
March 08, 2024 | 105.1% |
March 07, 2024 | 105.5% |
March 06, 2024 | 104.5% |
March 05, 2024 | 101.8% |
March 04, 2024 | 101.4% |
March 01, 2024 | 106.0% |
February 29, 2024 | 105.0% |
February 28, 2024 | 107.9% |
February 27, 2024 | 107.0% |
February 26, 2024 | 109.0% |
February 23, 2024 | 105.6% |
February 22, 2024 | 100.9% |
February 21, 2024 | 94.24% |
February 20, 2024 | 86.06% |
February 16, 2024 | 90.15% |
February 15, 2024 | 89.59% |
February 14, 2024 | 79.52% |
February 13, 2024 | 59.10% |
February 12, 2024 | 45.04% |
February 09, 2024 | 44.70% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-31.76%
Minimum
Apr 26 2022
160.8%
Maximum
Mar 18 2021
43.70%
Average
45.04%
Median
Feb 12 2024
1 Year Total Returns (Daily) Benchmarks
Charles River Laboratories International Inc | 15.76% |
Avid Bioservices Inc | -67.66% |
Iovance Biotherapeutics Inc | 98.42% |
Renovaro Inc | 88.60% |
Candel Therapeutics Inc | 297.9% |